We have all seen the bumper stickers that read: “No Farms, No Food”. I think the sentiment is pretty clear – the food that makes it to our tables doesn’t magically appear – it takes a long process that ultimately starts at a farm somewhere. I was thinking about how this relates to the pharmaceutical industry and came up with a similar slogan
The Facility of the Year Awards Judging Panel has named six Category Award Winners in the 2013 Facility of the Year Awards (FOYA) program. The winning projects for 2013 were selected from 27 well-qualified entries.
2012 Facility of the Year Awards Program Names Merck’s Vaccine Bulk Manufacturing Facility (VBF) Program of Projects as Overall WinnerNovember 12, 2012 8:16 am | News | Comments
ISPE announced during the Plenary Session at its 2012 Annual Meeting in San Francisco, Calif. USA, that Merck’s Vaccine Bulk Manufacturing Facility (VBF) Program of Projects is the Overall Winner of the 2012 Facility of the Year Awards (FOYA) program.
Roche's refurbishing project helps double R&D output and wins 2012 Facility of the Year Award for Operational Excellence.
Rentschler’s flexible facility wins 2012 FOYA award for Equipment Innovation.
Unique partnerships help NIBRT earn FOYA’s 2012 Special Recognition for Novel Collaboration award.
Merck’s modular method helps the company win the 2012 FOYA Award for Facility Integration.
Eisai's fourth knowledge center wins 2012 Facility of the Year Award for Project Execution.
Chiesi's energy efficiency efforts lead to 2012 Facility of the Year Award for Sustainability.
ISPE, the International Society for Pharmaceutical Engineering, today announced the appointment of Nancy S. Berg as President and CEO, effective 1 January 2012.
ISPE announced during the Keynote Session at its 2011 Annual Meeting in Grapevine, Texas, USA, that MedImmune’s Frederick Manufacturing Center (FMC) Expansion Facility is the Overall Winner of the 2011 Facility of the Year Awards (FOYA) program.
Novavax, Inc. announced today the appointment of Timothy J. Hahn, Ph.D., as Senior Vice President of Manufacturing. Dr. Hahn will oversee production of the company's vaccines and vaccine candidates and be responsible for all manufacturing operations at its pilot and commercial launch facility in Rockville, MD.
Roche’s MyDose project wins Process Innovation category in the ISPE/INTERPHEX/Pharmaceutical Processing Facility of the Year Awards.
Pfizer Health AB’s Project Pegasus team created an environment where operational improvements and innovation are encouraged and applied.
Pfizer's Freiberg SPRING-E MAP Plan proves cost savings and sustainability are not mutually exclusive
Creating a center of "eggs" ellence for modern vaccine production.
Shire Human Genetic Therapies’ Atlas Project recognized with Honorable Mention in ISPE/INTERPHEX/Pharmaceutical Processing Facility of the Year Award.
Merck's new global clinical supplies facility expands to meet market needs
MedImmune proved that aggressive construction and validation timelines can be achieved without sacrificing worker safety.
Six pharmaceutical manufacturing facilities constructed in Germany, Switzerland, Sweden, and the USA have been selected as Category Winners in the seventh annual Facility of the Year Awards (FOYA) program sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine.
Genentech's ECP-1 Bacterial Manufacturing Facility Named 2010 Facility of the Year Awards Overall WinnerNovember 8, 2010 5:07 am | Articles | Comments
ISPE , has announced during the Keynote Session at its 2010 Annual Meeting in Orlando, Florida, USA, that Genentech’s ECP-1 Bacterial Manufacturing Facility is the overall winner of the 2010 Facility of the Year Awards (FOYA) program
Pfizer Biotechnology Ireland has constructed the Monoclonal Antibodies (MAbs) Small Scale Facility (SSF) at Shanbally, Ringaskiddy, Co. Cork, Ireland. The facility, which is Pfizer’ s first biotechnology greenfield development, is a phase 2B/3 clinical trial product facility designed to manufacture, purify, formulate and bulk fill mammalian cell culture derived proteins.
Supply chain security is a chief concern throughout the pharmaceutical industry. ISPE's “Supply Chain Security: A Comprehensive and Practical Approach” illustrates how an integrated approach can help address pharmaceutical supply chain security concerns, such as preventing and detecting adulteration, counterfeiting, illegal diversion, and theft.
With a singular vision of purpose, and a drive to do "what’s best for the patient", Genentech’s ECP-1 project in Tuas, Singapore was completed 2 weeks ahead of a very aggressive 24 month schedule.
The over arching mission of the Building 22, Large-Scale Manufacturing (LSM) Technology Map Project was to enhance Biogen Idec’s world class bulk biologics production facility in Research Triangle Park, North Carolina to support long-term corporate initiatives.